# Nuvation Bio (NUVB) — Overview

NUVB · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/nuvb

## Price

Last close $4.75 on Oct 15, 2026. 52-week range $3.41 – $9.54.

## Company profile

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $169.9M |
| Revenue (quarter) | $31.7M |
| Revenue growth (year over year) | 555.64% |
| Gross profit (trailing twelve months) | $149.8M |
| Gross margin | 88.18% |
| Net income (trailing twelve months) | −$149.8M |
| Net income (quarter) | −$62.8M |
| Net income growth (year over year) | -6.50% |
| Net margin | -88.19% |
| Return on equity | -47.81% |
| EPS (trailing twelve months) | −$0.44 |
| Book value per share | $0.73 |
| P/E (trailing twelve months) | — |
| Price to book | 6.6 |
| Debt to assets | 65.90% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Nuvation Bio (NUVB) profitable?

No. Nuvation Bio reported a net loss of $149.8M over the trailing twelve months.

### How much revenue does Nuvation Bio (NUVB) make?

Nuvation Bio generated $169.9M in revenue over the trailing twelve months, up 555.64% year over year.

### How do I buy stock in Nuvation Bio (NUVB)?

NUVB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).